Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Diamant Thaçi
◽
Bruce Strober
◽
Kenneth B. Gordon
◽
Peter Foley
◽
Melinda Gooderham
◽
...
Janice S. H. Tan
◽
Jonathan Y. H. Teh
◽
Laura L. Y. Tan
◽
Sheena X. F. Tan
◽
You Quan Li
◽
...
2017 ◽
Vol 124
(3)
◽
pp. 521-529
◽
John V. Hegde
◽
Narek Shaverdian
◽
Megan E. Daly
◽
Carol Felix
◽
Deborah L. Wong
◽
...
2008 ◽
Vol 58
(2)
◽
pp. AB128
2018 ◽
Vol 124
(13)
◽
pp. 2841-2849
◽
Margaret K. Guerriero
◽
Mary W. Redman
◽
Kelsey K. Baker
◽
Renato G. Martins
◽
Keith Eaton
◽
...
2014 ◽
Vol 90
(1)
◽
pp. S181-S182
C.R. Spencer
◽
H.A. Gay
◽
T.A. DeWees
◽
T. Wildes
◽
L. Michel
◽
...
2018 ◽
Vol 100
(2)
◽
pp. 374-382
◽
Steven J. Frank
◽
Thomas J. Pugh
◽
Pierre Blanchard
◽
Usama Mahmood
◽
William J. Graber
◽
...
2011 ◽
Vol 64
(2)
◽
pp. AB160
2011 ◽
Vol 64
(2)
◽
pp. AB156
2016 ◽
Vol 95
(5)
◽
pp. 1429-1438
◽
Shariq S. Khwaja
◽
Amit Roy
◽
Stephanie Markovina
◽
Todd A. Dewees
◽
Steven Hunt
◽
...
2017 ◽
Vol 133
(3)
◽
pp. 623-631
◽
Kathryn M. Field
◽
Madeleine T. King
◽
John Simes
◽
David Espinoza
◽
Elizabeth H. Barnes
◽
...